Global Dermatomyositis Market: Restraint
The drugs used for the treatment of dermatomyositis may cause some side effects or adverse events, which is expected to hinder the global dermatomyositis market growth over the forecast period
For instance, the drug Octagam 10% (Immune globulin (human)) approved for adult dermatomyositis causes headache, nausea, anaphylactic reactions, thrombosis, and in rare cases may cause side effects such as hemolytic anemia, aseptic meningitis syndrome, and transfusion-related acute lung injury (TRALI)
Some of the common side effects of Dermatomyositis drugs are: Pain and swelling at injection site, mild headache, fainting and dizziness, back pain, abdominal pain and muscle cramps, and minor chest pain.
Dermatomyositis Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients